Emergent BioSolutions (EBS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist

8.100
+0.040+0.50%

Close Dec 20 16:00 ET

8.100
0.0000.00%

Post 20:01 ET

438.89MMarket Cap-2.07P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Sector Update: Health Care
MT NewswiresDec 16 15:42 ET
Emergent BioSolutions Wins $50 Million Contract Option for Cyfendus; Shares Rise
MT NewswiresDec 16 11:37 ET
Express News | Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025
ReutersDec 16 08:00 ET
Express News | Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)
ReutersDec 16 08:00 ET
Investors Don't See Light At End Of Emergent BioSolutions Inc.'s (NYSE:EBS) Tunnel And Push Stock Down 26%
Simply Wall StDec 10 05:20 ET
Emergent BioSolutions Inc.'s (NYSE:EBS) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains
Simply Wall StDec 8 07:41 ET

Comments

Jaguar8

Dec 16 22:18

🟢Watchlist TUESDAY 12/17… quite busy. Squeezing in. NFA

$Tenaya Therapeutics (TNYA.US)$ Trial data on hypertrophic cardiomyopathy (HCM) at 8AM ET. Large float. SI 25.47%. COH $129.9M good for 16.2 months
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months✅
$Maison Solutions (MSS.US)$ PR AH 12/...

Jaguar8

Dec 16 07:12

NEWS

$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions (NYSE: EBS) has received a $50 million contract option from BARDA for its CYFENDUS® anthrax vaccine. The deliveries are scheduled between now and April 2025. This follows a previous $30 million contract modification for the same vaccine. CYFENDUS®, FDA-approved in July 2023, is a two-dose anthrax vacci...

Trytosaveabit

Dec 16 07:02

News

$Emergent BioSolutions (EBS.US)$ Reuters
Just
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted
Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025

EZ_money

Dec 10 13:16

$Emergent BioSolutions (EBS.US)$ 👈 this small float is the maker of narcan the drug that saves lives from opioid overdoses. Huge in the United States because of the cartels pushing fentanyl all over killing everyone.Hit them with narcan it's already saved countless lives. States are starting to require they have some on hand in schools. narcan will be sold all over in every pharmacy, sold to schools , jails, hospitals etc....only one thing like it but doesn't work on fentanyl like narcan does. N...

Emergent BioSolutions Inc.'s (NYSE:EBS) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains

EZ_money

Dec 10 05:22

$Emergent BioSolutions (EBS.US)$ buying back in ... BlackRock, vanguard purposely push assets down. this company has far too many good things happening with new CEO turning things around starting past year. it's bottomed out earlier this year guess who are the ones pushing it down.... they are the ones wanting to buy in cheaper
$Synopsys (SNPS.US)$ $Futu Holdings Ltd (FUTU.US)$ $IonQ Inc (IONQ.US)$